Trial Profile
Phase IIa study of tesetaxel as 2nd-line treatment of patients with advanced breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2010
Price :
$35
*
At a glance
- Drugs Tesetaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 09 Nov 2010 New trial record